Company page

Bioceltix Sa

Bioceltix Sa, trading under the ticker BCX, is a public company based in Poland with a market capitalization of approximately 131.65 million. The company is focused on developing innovative biopharmaceutical solutions. Bioceltix aims to address unmet medical needs through its research and development efforts in the biotechnological sector.

profileBCX:GPWAI content: aiUpdated June 24, 2026/company/bioceltix-sa/c-uebkqar0
Bioceltix Sa logo
Ticker
BCX:GPW
Asset type
Stock
Market cap
$131.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GPW
Currency
PLN